GGrantIndex
← Leaderboards

Myriam Fornage

University Of California At Davis

Google Scholar ↗PubMed ↗ORCID ↗
$21,359,505
Attributed
$48,375,795
Total exposure
14
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $19.4M · FY2007–25
$20M$15M$10M$5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$93,644,532 · 15

By mechanism

U19$45,268,737 · 1
U01$24,254,769 · 5
R01$9,993,494 · 5
RF1$6,630,354 · 1
UH3$3,045,497 · 1
UF1$2,412,788 · 1

Top collaborators

Most similar at University Of California At Davis

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos”

Research focus

Alzheimer&AposGeneticCohortGenesAfrican AmericanAgingParticipantMagnetic Resonance ImagingHeartPhenotypeStrokeGenome Wide Association StudyResourcesSamplingResearch PersonnelS DiseaseDementiaCollaborationsBrainBaseCommunitiesGenomic EpidemiologyRisk FactorsVariant

Grant awards (55)

The Clinical Significance of Incidental White Matter Lesions on MRI Amongst a Diverse Population with Cognitive Complaints (INDEED)$9,311,480
U19 · FY2025 · NS
Genetics of deep-learning-derived neuroimaging endophenotypes for Alzheimer's Disease$1,134,253
U01 · FY2025 · AG
Multiethnic Validation of VCID biomarkers in South Texas$949,277
U01 · FY2025 · NS
The Clinical Significance of Incidental White Matter Lesions on MRI Amongst a Diverse Population with Cognitive Complaints (INDEED)$10,005,568
U19 · FY2024 · NS
Multiethnic Validation of VCID biomarkers in South Texas$1,184,613
U01 · FY2024 · NS
Genetics of deep-learning-derived neuroimaging endophenotypes for Alzheimer's Disease$1,146,699
U01 · FY2024 · AG
The Clinical Significance of Incidental White Matter Lesions on MRI Amongst a Diverse Population with Cognitive Complaints (INDEED)$9,503,062
U19 · FY2023 · NS
Multiethnic Validation of VCID biomarkers in South Texas$1,192,048
U01 · FY2023 · NS
Genetics of deep-learning-derived neuroimaging endophenotypes for Alzheimer's Disease$1,140,708
U01 · FY2023 · AG
Genetics of deep-learning-derived neuroimaging endophenotypes for Alzheimer's Disease (Parent grant)$380,624
U01 · FY2023 · AG
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches$2,147,504
U01 · FY2022 · AG
Genetics of deep-learning-derived neuroimaging endophenotypes for Alzheimer's Disease$1,130,475
U01 · FY2022 · AG
Genetics of deep-learning-derived neuroimaging endophenotypes for Alzheimer's Disease$373,746
U01 · FY2022 · AG
Genetics of deep-learning-derived neuroimaging endophenotypes for Alzheimer's Disease (Parent grant)$323,239
U01 · FY2022 · AG
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches$32,137
U01 · FY2022 · AG
The Clinical Significance of Incidental White Matter Lesions on MRI Amongst a Diverse Population with Cognitive Complaints (INDEED)$13,212,214
U19 · FY2021 · NS
Multiethnic Validation of VCID biomarkers in South Texas$2,412,788
UF1 · FY2021 · NS
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches$2,153,560
U01 · FY2021 · AG
Genetics of deep-learning-derived neuroimaging endophenotypes for Alzheimer's Disease$1,406,276
U01 · FY2021 · AG
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches$128,552
U01 · FY2021 · AG
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches$112,663
U01 · FY2021 · AG
The Clinical Significance of Incidental White Matter Lesions on MRI Amongst a Diverse Population with Cognitive Complaints (INDEED)$3,236,413
U19 · FY2020 · NS
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches$2,158,021
U01 · FY2020 · AG
Microglial, Inflammatory and Omics Markers of Cerebral Small Vessel Disease in the CHARGE Consortium$974,558
UH3 · FY2020 · NS
ADSP Follow-up in Multi-Ethnic Cohorts via Endophenotypes, Omics & Model Systems$298,028
U01 · FY2020 · AG
Neurocognitive aging, MCI and Alzheimer's disease DNA methylation among diverse Latinos$6,630,354
RF1 · FY2019 · AG
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches$2,164,820
U01 · FY2019 · AG
Microglial, Inflammatory and Omics Markers of Cerebral Small Vessel Disease in the CHARGE Consortium$989,999
UH3 · FY2019 · NS
ADSP Follow-up in Multi-Ethnic Cohorts via Endophenotypes, Omics & Model Systems$374,449
U01 · FY2019 · AG
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches$2,233,154
U01 · FY2018 · AG
Microglial, Inflammatory and Omics Markers of Cerebral Small Vessel Disease in the CHARGE Consortium$1,080,940
UH3 · FY2018 · NS
ADSP Follow-up in Multi-Ethnic Cohorts via Endophenotypes, Omics & Model Systems$320,303
U01 · FY2018 · AG
Microglial, Inflammatory and Omics Markers of Cerebral Small Vessel Disease in the CHARGE Consortium$1,001,222
UH2 · FY2017 · NS
An Integrated Genetic and Epigenetic Approach to Cerebral Small Vessel Disease$609,515
R01 · FY2017 · NS · contact PI
Microglial, Inflammatory and Omics Markers of Cerebral Small Vessel Disease in the CHARGE Consortium$1,037,671
UH2 · FY2016 · NS
ADSP Follow-up in Multi-Ethnic Cohorts via Endophenotypes, Omics & Model Systems$634,356
U01 · FY2016 · AG
An Integrated Genetic and Epigenetic Approach to Cerebral Small Vessel Disease$602,387
R01 · FY2016 · NS · contact PI
An Integrated Genetic and Epigenetic Approach to Cerebral Small Vessel Disease$602,099
R01 · FY2015 · NS · contact PI
An Integrated Genetic and Epigenetic Approach to Cerebral Small Vessel Disease$641,768
R01 · FY2014 · NS · contact PI
A Genome-Wide Association Study of Ischemic Brain Vascular Injury$749,635
R01 · FY2010 · HL · contact PI
Genes of the CYP450-Derived Eicosanoids Pathway in Subclinical Atherosclerosis$682,600
R01 · FY2010 · HL · contact PI
A Genome-Wide Association Study of Ischemic Brain Vascular Injury$800,767
R01 · FY2009 · HL · contact PI
Genes of the CYP450-Derived Eicosanoids Pathway in Subclinical Atherosclerosis$699,195
R01 · FY2009 · HL · contact PI
GWAS of longitudinal blood pressure profiles from young adulthood to middle-age$559,427
U01 · FY2009 · HG · contact PI
Genes of the CYP450-Derived Eicosanoids Pathway in Subclinical Atherosclerosis$699,529
R01 · FY2008 · HL · contact PI
GWAS of longitudinal blood pressure profiles from young adulthood to middle-age$575,837
U01 · FY2008 · HG · contact PI
Genes of the CYP450-Derived Eicosanoids Pathway in Subclinical Atherosclerosis$716,074
R01 · FY2007 · HL · contact PI
Gene-Environment Interactions and Stroke Susceptibility$421,594
R01 · FY2004 · HL
FUNCTIONAL GENOMICS OF ARTERIAL THROMBOSIS$371,250
R01 · FY2004 · NS
Gene-Environment Interactions and Stroke Susceptibility$420,472
R01 · FY2003 · HL
FUNCTIONAL GENOMICS OF ARTERIAL THROMBOSIS$371,250
R01 · FY2003 · NS
Gene-Environment Interactions and Stroke Susceptibility$436,568
R01 · FY2002 · HL
FUNCTIONAL GENOMICS OF ARTERIAL THROMBOSIS$372,500
R01 · FY2002 · NS
Gene-Environment Interactions and Stroke Susceptibility$422,749
R01 · FY2001 · HL
FUNCTIONAL GENOMICS OF ARTERIAL THROMBOSIS$373,542
R01 · FY2001 · NS